A novel macrolide analog F806 suppressed more effectively ESCC cell growth in vitro and in vivo via initiation of anoikis and subsequent apoptosis by blocking ITGB1 activation compared with siRNA-mediated ITGB1 knockdown55. Here, ITGB1 is linked to esophageal squamous cell carcinoma.